uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
17.95
+0.22 (1.24%)
At close: Sep 5, 2025, 4:00 PM
18.00
+0.05 (0.28%)
After-hours: Sep 5, 2025, 6:54 PM EDT
uniQure Employees
uniQure had 209 employees as of December 31, 2024. The number of employees decreased by 271 or -56.46% compared to the previous year.
Employees
209
Change (1Y)
-271
Growth (1Y)
-56.46%
Revenue / Employee
$68,598
Profits / Employee
-$952,129
Market Cap
1.22B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 209 | -271 | -56.46% |
| Dec 31, 2023 | 480 | -21 | -4.19% |
| Dec 31, 2022 | 501 | 38 | 8.21% |
| Dec 31, 2021 | 463 | 131 | 39.46% |
| Dec 31, 2020 | 332 | 84 | 33.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
QURE News
- 1 day ago - uniQure: Getting Nervous Ahead Of Critical Huntington's Gene Therapy Data - Seeking Alpha
- 1 day ago - uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease - GlobeNewsWire
- 5 weeks ago - What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday? - Benzinga
- 5 weeks ago - uniQure N.V. (QURE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 6 weeks ago - uniQure to Announce Second Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - uniQure Announces Appointment of Kylie O'Keefe as Chief Customer and Strategy Officer - GlobeNewsWire
- 3 months ago - uniQure Provides Regulatory Update on AMT-130 for Huntington's Disease - GlobeNewsWire